This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
home-builder: Archive
After Golden Cross, Invesco (IVZ)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
IVZNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is Hennessy Gas Utility Investor (GASFX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for GASFX
GASFXPositive Net Change
equity home-builder mutual-funds
Is MFS Growth Fund A (MFEGX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for MFEGX
MFEGXNegative Net Change
equity home-builder mutual-funds
Is Parnassus Mid-Cap Investor (PARMX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for PARMX
PARMXNegative Net Change
equity home-builder mutual-funds
Is Thrivent Large Cap Value Fund S (TLVIX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for TLVIX
TLVIXNegative Net Change
equity home-builder mutual-funds
Is Brown Capital Management Small Company Investor (BCSIX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for BCSIX
BCSIXPositive Net Change
equity home-builder mutual-funds
Should You Buy Medpace (MEDP) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
MEDPNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is Franklin Income Advisor (FRIAX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FRIAX
FRIAXNegative Net Change
equity home-builder mutual-funds
Is Fidelity Focused Stock Fund (FTQGX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FTQGX
FTQGXNegative Net Change
equity home-builder mutual-funds
Is American Funds New World A (NEWFX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for NEWFX
NEWFXNegative Net Change
equity home-builder mutual-funds
Is Fidelity Advisor Biotechnology A (FBTAX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FBTAX
FBTAXPositive Net Change
equity home-builder mutual-funds
Is Fidelity Asset Manager 50% (FASMX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FASMX
FASMXNegative Net Change
equity home-builder mutual-funds
TEMENOS GROUP (TMSNY)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
TMSNYNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
TransAlta (TAC) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
TACPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Prime Medicine, Inc. (PRME) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
PRMEPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Regions Financial (RF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
RFNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is Cohen & Steers Realty Shares L (CSRSX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for CSRSX
CSRSXNegative Net Change
equity home-builder mutual-funds
Is Macquarie Science & Technology Y (WSTYX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for WSTYX
WSTYXNegative Net Change
equity home-builder mutual-funds
Is BNY Mellon SC Stock Index Inv (DISSX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for DISSX
DISSXNegative Net Change
equity home-builder mutual-funds
Is Schwab International Core Equity (SICNX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for SICNX
SICNXNegative Net Change
equity home-builder mutual-funds
Is T. Rowe Price Retirement Balanced (TRRIX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for TRRIX
TRRIXNegative Net Change
equity home-builder mutual-funds
Should You Buy AppFolio (APPF) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
APPFPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
F.N.B. (FNB)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
FNBNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Amgen (AMGN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
AMGNPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is Franklin Natural Resources A (FRNRX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FRNRX
FRNRXNegative Net Change
equity home-builder mutual-funds